Cytokeratin 8 Mouse Monoclonal Antibody [A1-B11]
Usd: 350 Special Discount
Specification
Catalog# M1603-2
Cytokeratin 8 Mouse Monoclonal Antibody [A1-B11]
-
WB
-
IF-Cell
-
IHC-P
-
FC
-
Human
-
Mouse
-
Rat
-
unconjugated
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_M1603-2_Europe.pdf
- No MSDS Found
Overview
Product Name
Cytokeratin 8 Mouse Monoclonal Antibody [A1-B11]
Antibody Type
Mouse Monoclonal Antibody
Immunogen
Synthetic peptide within C-terminal human Cytokeratin 8 aa 441-483.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, IHC-P, FC
Target Molecular Weight
53 kDa
Positive Control
HeLa, A549, MCF7, PANC-1, human breast carcinoma tissue, human colon cancer tissue, mouse small intestine tissue, Hela.
Conjugation
unconjugated
Clone Number
A1-B11
RRID
Product Features
Form
Liquid
Concentration
2 mg/mL.(The concentration of this product may be batch-dependent)
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG1
Purification Method
Immunogen affinity purified.
Application Dilution
-
WB
-
1:1,000-1:2,000
-
IF-Cell
-
1:100-1:500
-
IHC-P
-
1:50-1:200
-
FC
-
1:50-1:100
Target
Function
Cytokeratins comprise a diverse group of intermediate filament proteins (IFPs) that are expressed as pairs in both keratinized and non-keratinized epithelial tissue. Cytokeratins play a critical role in differentiation and tissue specialization and function to maintain the overall structural integrity of epithelial cells. They have been found to be useful markers of tissue differentiation, which is directly applicable to the characterization of malignant tumors. Cytokeratin 8 expression is seen in epithelium and epithelium-derived tumors. The Cytokeratin 8 and 18 pair are normally expressed in simple epithelia, but not in stratified epithelial cells. Research indicates that squamous cell carcinomas derived from stratified epithelia show abnormal expression of Cytokeratin 8 and 18, although it is not known whether these proteins contribute to the malignant phenotype of the cells. Expression of Cytokeratin 8 and 18 in oral squamous cell carcinomas is an independent prognostic marker that indicates a poor prognosis. Cytokeratin 8 expression correlates with malignancy in leukoplakia and carcinomas of the head and neck; it is expressed in all non-small-cell lung cancers. Cytokeratin 8 has been shown to possess extracellular epitopes on tumor cells, which may represent valuable targets for therapy.
Background References
1. Xu D et al. Fialuridine induces acute liver failure in chimeric TK-NOG mice: a model for detecting hepatic drug toxicity prior to human testing. PLoS Med 11:e1001628 (2014).
2. Berger PL et al. Transient Induction of ING4 by Myc Drives Prostate Epithelial Cell Differentiation and Its Disruption Drives Prostate Tumorigenesis. Cancer Res 74:3357-68 (2014).
Sequence Similarity
Belongs to the intermediate filament family.
Tissue Specificity
Observed in muscle fibers accumulating in the costameres of myoplasm at the sarcolemma membrane in structures that contain dystrophin and spectrin. Expressed in gingival mucosa and hard palate of the oral cavity.
Post-translational Modification
Phosphorylation on serine residues is enhanced during EGF stimulation and mitosis. Ser-74 phosphorylation plays an important role in keratin filament reorganization.; O-glycosylated. O-GlcNAcylation at multiple sites increases solubility, and decreases stability by inducing proteasomal degradation.; O-glycosylated (O-GlcNAcylated), in a cell cycle-dependent manner.
Subcellular Location
Cytoplasm, Nucleus, Nucleus matrix.
Synonyms
CARD2 antibody
CK 8 antibody
CK-8 antibody
CK8 antibody
CYK8 antibody
CYKER antibody
Cytokeratin endo A antibody
Cytokeratin-8 antibody
DreK8 antibody
EndoA antibody
ExpandCARD2 antibody
CK 8 antibody
CK-8 antibody
CK8 antibody
CYK8 antibody
CYKER antibody
Cytokeratin endo A antibody
Cytokeratin-8 antibody
DreK8 antibody
EndoA antibody
K2C8 antibody
K2C8_HUMAN antibody
K8 antibody
Keratin 8 antibody
Keratin type II cytoskeletal 8 antibody
Keratin, type II cytoskeletal 8 antibody
Keratin-8 antibody
KO antibody
Krt 2.8 antibody
KRT8 antibody
MGC118110 antibody
MGC174782 antibody
MGC53564 antibody
MGC85764 antibody
sb:cb186 antibody
Type-II keratin Kb8 antibody
CollapseImages
-
Western blot analysis of Cytokeratin 8 on different lysates with Mouse anti-Cytokeratin 8 antibody (M1603-2) at 1/2,000 dilution.
Lane 1: HeLa (Human cervical adenocarcinoma cells)cell lysate
Lane 2: A549 (Human lung adenocarcinoma cell) cell lysate
Lane 3: MCF7 (Human breast cancer cell) cell lysate
Lysates/proteins at 30 µg/Lane.
Exposure time: 24 seconds; ECL: K1801
Blocking: 5% NFDM/TBST, 1 hour at room temperature
Primary antibody: M1603-2, 1/2,000 in 5% NFDM/TBST, overnight at 4 ℃
Secondary antibody: Goat anti-Mouse IgG-HRP (HA1006), 1/50,000 in 5% NFDM/TBST, 1 hour at room temperature
Predicted band size: 53.7 kDa
Observed band size: 40-54 kDa -
Immunocytochemical staining of MCF-7 cells using anti-Cytokeratin 8 Mouse mAb.
-
Immunocytochemical staining of PANC-1 cells using anti-Cytokeratin 8 Mouse mAb.
-
Immunohistochemical analysis of paraffin- embedded human colon cancer tissue using anti-Cytokeratin 8 Mouse mAb.
-
Immunohistochemical analysis of paraffin- embedded human breast carcinoma tissue using anti-Cytokeratin 8 Mouse mAb.
-
Immunohistochemical analysis of paraffin- embedded mouse small intestine tissue using anti-Cytokeratin 8 Mouse mAb.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Oxidative stress and Kras mutation in Mist1+ cells act in a double-hit manner to drive gastric tumorigenesis
Journal: Cell Reports
DOI: 10.1016/j.celrep.2025.116014
IF: 6.9
Application: IF-cell
Reactivity: Mouse
Publish date: 2025 Jul
-
Single cell profiling of female breast fibroadenoma reveals distinct epithelial cell compositions and therapeutic targets.
Journal:
DOI:
IF: 17.694
Application:
Reactivity: Human
Publish date: 2023 Jun
Alternative Products
Cytokeratin 8 Recombinant Antibody [SU0338] - Mouse IgG1 (Chimeric)
Application: IF-Cell,IHC-P
Reactivity: Human
Conjugate: unconjugated
Cytokeratin 8 Recombinant Rabbit Monoclonal Antibody [SU0338]
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Products with the same target and pathway
Cytokeratin 8 Recombinant Antibody [SU0338] - Mouse IgG1 (Chimeric)
Application: IF-Cell,IHC-P
Reactivity: Human
Conjugate: unconjugated
iFluor™ 647 Conjugated Cytokeratin 8 Recombinant Rabbit Monoclonal Antibody [SU0338]
Application: IF-Tissue,IF-Cell,FC
Reactivity: Human,Mouse
Conjugate: iFluor™ 647
Cytokeratin 8 Recombinant Rabbit Monoclonal Antibody [SU0338] - BSA and Azide free
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Cytokeratin 8 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Cytokeratin 8 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Cytokeratin 8 Recombinant Antibody [SU0338] - Mouse IgG1 (Chimeric) - BSA and Azide free
Application: IF-Cell,IHC-P
Reactivity: Human
Conjugate: unconjugated
Cytokeratin 8 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
iFluor™ 488 Conjugated Cytokeratin 8 Recombinant Rabbit Monoclonal Antibody [SU0338]
Application: IF-Tissue,IF-Cell,FC
Reactivity: Human
Conjugate: iFluor™ 488
Cytokeratin 8 Recombinant Rabbit Monoclonal Antibody [SU0338]
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
iFluor™ 594 Conjugated Cytokeratin 8 Recombinant Rabbit Monoclonal Antibody [SU0338]
Application: IF-Tissue,IF-Cell,FC
Reactivity: Human,Mouse
Conjugate: iFluor™ 594